PARSIPPANY, N.J. and TEL AVIV, Israel, May 17, 2016. Medinol announced outstanding results from the NIREUS trial for BioNIR™, its new coronary stent system and the first ever elastomeric Drug Eluting Stent... more
Medinol
News
News
-
-
NIRTRAKS Study of a Novel Coronary Stent Enrolls its First Patient
PARSIPPANY, N.J., - Medinol is pleased to announce the enrollment of their first patient in the U.S. NIRTRAKS Study. NIRTRAKS is a post marketing, non-randomized study of the NIRxcell™... more
-
Medinol U.S. Commercializes Novel Coronary Stent
PARSIPPANY, N.J., - During the recent 2015 Transcatheter Cardiovascular Therapeutics Meeting held in San Francisco, CA, Medinol Ltd. continued to introduce novel stent solutions to the coronary marketplace... more
-
Medinol Completes Enrollment in Randomized, Multicenter, Pivotal Study of eDES™ Coronary Stent System
PARSIPPANY, N.J., - Medinol announced today the completion of enrollment in its BIONICS trial, a global, prospective, randomized, multicenter, clinical trial designed to evaluate... more